As for those with hyperglycemia with or without hypertension at baseline, relacorilant significantly improved fasting glucose ...

In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

“Baxdrostat BaxHTN Phase III trials on patients with uncontrolled or treatment-resistant hypertension demonstrated a ...

Delayed diagnosis of hypertension after initial elevated BP measurement was tied to lower rates of antihypertensive drug ...

Researchers found a 30% increased risk of cardiovascular events in patients whose diagnosis was delayed by more than a year ...

AstraZeneca’s $1.3 billion bet on CinCor Pharma and its mid-phase hypertension drug baxdrostat seems to have paid off based ...

Discover why leading doctor Dr. Shirley Koeh advocates for potassium alongside salt reduction to effectively manage high ...

At two doses, baxdrostat demonstrated significant reduction in mean seated systolic BP vs. placebo at 12 weeks among patients ...

The BaxHTN study met its primary endpoint, and researchers will present more data at the ESC Congress later this summer.

A new study published in the journal of Hypertension showed that the white matter hyperintensity volume was higher 15 years ...

Discover why customizable blood pressure alerts in EMRs, combined with team-based workflows, may be key to catching more ...

In addition to taking medication, paying attention to these habits can help maintain healthy blood pressure levels..resistant ...